U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H23N3O
Molecular Weight 345.4375
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PF-750

SMILES

O=C(NC1=CC=CC=C1)N2CCC(CC3=CC4=CC=CC=C4N=C3)CC2

InChI

InChIKey=BIODYGOZWZNCAG-UHFFFAOYSA-N
InChI=1S/C22H23N3O/c26-22(24-20-7-2-1-3-8-20)25-12-10-17(11-13-25)14-18-15-19-6-4-5-9-21(19)23-16-18/h1-9,15-17H,10-14H2,(H,24,26)

HIDE SMILES / InChI

Molecular Formula C22H23N3O
Molecular Weight 345.4375
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

PF-750 is a covalent irreversible inhibitor of FAAH, discovered by Pfizer.

Originator

Curator's Comment: # Pfizer

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
16.2 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
A second fatty acid amide hydrolase with variable distribution among placental mammals.
2006 Dec 1
Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity.
2007 Nov 13
SAR and LC/MS studies of β-lactamic inhibitors of human fatty acid amide hydrolase (hFAAH): evidence of a nonhydrolytic process.
2011 Oct 13
Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas.
2011 Oct 13

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
FAAH activity was measured by following the production of ammonia generated from the hydrolysis of oleamide by FAAH. GDH catalyzes the condensation of ammonia and R-ketoglutarate to glutamate with a concomitant conversion of NADH to nicotinamide adenine dinucleotide, oxidized form (NAD+), which is spectrophotometrically measured at 340 nm. To determine IC50, the reactions were carried out in 96-well clear polystyrene plates in a total volume of 200 uL. To a reaction mixture (140 uL) containing NaPi, pH 7.4, NADH, R-ketoglutarate, ADP, EDTA, and GDH to final concentrations of 50 mM, 150 uM, 3 mM, 2 mM, 1 mM, and 7.5 unit/mL, respectively, was added 20 uL of PF-750 dissolved in 50% DMSO (20 uL of 50% DMSO for controls). After the resulting mixture was mixed in a plate vortex, 20 uL of hFAAH (370 ng) in 20 mM NaPi, pH 7.8/1% Triton X-100, was added and mixed. After this mixture was preincubated at RT for the indicated period of time (5-60 min), the reaction was initiated by addition of 20 uL of 500 uM oleamide dissolved in 25% DMSO and 75% EtOH.The reactions were incubated at 30 °C, and the absorbance at 340 nm was collected over a period of 30 min. IC50 for PF-750 was time-dependend, and varied from 0.595 uM at 5 min pre-incubation to 0.0162 uM at 60 min pre-incubation
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:12:08 GMT 2023
Edited
by admin
on Sat Dec 16 08:12:08 GMT 2023
Record UNII
7756CPP14K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PF-750
Common Name English
1-PIPERIDINECARBOXAMIDE, N-PHENYL-4-(3-QUINOLINYLMETHYL)-
Systematic Name English
Code System Code Type Description
CAS
959151-50-9
Created by admin on Sat Dec 16 08:12:08 GMT 2023 , Edited by admin on Sat Dec 16 08:12:08 GMT 2023
PRIMARY
FDA UNII
7756CPP14K
Created by admin on Sat Dec 16 08:12:08 GMT 2023 , Edited by admin on Sat Dec 16 08:12:08 GMT 2023
PRIMARY
PUBCHEM
25154868
Created by admin on Sat Dec 16 08:12:08 GMT 2023 , Edited by admin on Sat Dec 16 08:12:08 GMT 2023
PRIMARY
EPA CompTox
DTXSID00648906
Created by admin on Sat Dec 16 08:12:08 GMT 2023 , Edited by admin on Sat Dec 16 08:12:08 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY